Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Participants were randomly assigned to one of five therapies: exenatide alone, dapagliflozin alone, dual therapy of exenatide and dapagliflozin, combined dapagliflozin and metformin therapy, or the weight-loss medication phentermine/topiramate extended-release
[PMID: 23940435] PubMed record related to this compound for laboratory literature review
Natural flavors are fruit and berry extracts and contain no MSG
They are approved only for type 2 diabetes management and, for specific agents like semaglutide (Wegovy) and liraglutide (Saxenda), chronic weight management in adults with obesity or overweight with comorbidities
US$ 26.57
US$ 28.10
US$ 20.32
US$ 29.78
US$ 23.01
